Senior insider sale
Chief Financial Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$92.0K
5.45K shares
What this filing means
GRUBER JAMES R. plans to sell 5.45K shares of ETON PHARMACEUTICALS, INC. valued at approximately $92.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001974078-25-000479
Officer· Chief Financial Officer
Since Apr 2022
5.45K
Shares to sell
$92.0K
Approx. market value
5.45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Grant
Grant
12/11/2025
5.45KTotal acquired5.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2025 | Grant Grant | 5.45K | — |
| Total | 5.45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.45K
Market value
$92.0K
12/12/2025
Total
Units
5.45K
Value
$92.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2025 | 5.45K | $92.0K | NASDAQ | Planned |
| Total | 5.45K | $92.0K | ||